{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:21Z","timestamp":1792791441404,"version":"4.5.0"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004881","name":"Instituto Mexicano del Seguro Social","doi-asserted-by":"publisher","award":["R-2020-785-095"],"award-info":[{"award-number":["R-2020-785-095"]}],"id":[{"id":"10.13039\/501100004881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.smim.2026.102025","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:12:48Z","timestamp":1775135568000},"page":"102025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["COVID-19 in Latin America: Clinical and immunological insights, vaccine development, and lessons for pandemic preparedness"],"prefix":"10.1016","volume":"82","author":[{"given":"Alejandro","family":"Torres-Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bautista-Sebasti\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Rivera-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ferat-Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Arriaga-Pizano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"C\u00e9rbulo-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Ram\u00edrez-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bonifaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana","family":"Pelayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0530-492X","authenticated-orcid":false,"given":"Constantino","family":"L\u00f3pez-Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2026.102025_bib1","series-title":"y el desarrollo social","article-title":"Informe COVID-19: La prolongaci\u00f3n de la crisis sanitaria y su impacto en la salud, la econom\u00eda","author":"United Nations","year":"2020"},{"key":"10.1016\/j.smim.2026.102025_bib2","article-title":"COVID-19 in Latin America: inequalities and response capacity of health systems to health emergencies","volume":"47","author":"dos Santos","year":"2023","journal-title":"Rev. Panam. De. Salud P\u00fablica\/Pan Am. J. Public Health"},{"key":"10.1016\/j.smim.2026.102025_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40121-022-00748-z","article-title":"COVID-19 in Latin America: a snapshot in time and the road ahead","volume":"12","author":"LaRotta","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.smim.2026.102025_bib4","doi-asserted-by":"crossref","DOI":"10.17159\/sajs.2022\/13475","article-title":"Challenges in addressing inequity in access to COVID-19 diagnostics, therapeutics and vaccines in Africa","volume":"118","author":"Rees","year":"2022","journal-title":"S Afr. J. Sci."},{"key":"10.1016\/j.smim.2026.102025_bib5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.51594\/imsrj.v4i4.1051","article-title":"Public-private partnerships in health sector innovation: lessons from around the world","volume":"4","author":"Charles","year":"2024","journal-title":"Int. Med. Sci. Res. J."},{"key":"10.1016\/j.smim.2026.102025_bib6","unstructured":"Prabhala Achal, Alsalhani Alain. Pharmaceutical firms across Asia, Africa and Latin America with potential to manufacture mRNA vaccines 2021. \u3008https:\/\/msfaccess.org\/pharmaceutical-firms-across-asia-africa-and-latin-america-potential-manufacture-mrna-vaccines\u3009 (accessed November 24, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib7","series-title":"Estudio Econ\u00f3mico de Am\u00e9rica Latina y el Caribe 2021: Din\u00e1mica laboral y pol\u00edticas de empleo para una recuperaci\u00f3n sostenible e inclusiva m\u00e1s all\u00e1 de la crisis del COVID-19","author":"Comisi\u00f3n Econ\u00f3mica para Am\u00e9rica Latina y el Caribe (CEPAL)","year":"2021"},{"key":"10.1016\/j.smim.2026.102025_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/B978-0-323-91307-2.00016-X","article-title":"The impact of COVID-19 on regional poverty: Evidence from Latin America","author":"Topcu","year":"2022","journal-title":"COVID-19 Sustain. Dev. Goals"},{"key":"10.1016\/j.smim.2026.102025_bib9","first-page":"46","article-title":"COVID-19 pandemic and the global economic situation: a year on","volume":"56","author":"Adjei-Mantey","year":"2023","journal-title":"PAMJ"},{"key":"10.1016\/j.smim.2026.102025_bib10","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","article-title":"Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020\u201321","volume":"399","author":"Wang","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2026.102025_bib11","unstructured":"The Economist. Tracking covid-19 excess deaths across countries 2021. \u3008https:\/\/www.economist.com\/graphic-detail\/coronavirus-excess-deaths-tracker\u3009 (accessed February 17, 2026)."},{"key":"10.1016\/j.smim.2026.102025_bib12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.20430\/ete.v89i355.1307","article-title":"Consecuencias de la covid-19 en la econom\u00eda y las finanzas p\u00fablicas en M\u00e9xico: m\u00e1s all\u00e1 de la pandemia","volume":"89","author":"Morales","year":"2022","journal-title":"Trimest. Econ."},{"key":"10.1016\/j.smim.2026.102025_bib13","unstructured":"Proyecto Argentino Interinstitucional de Gen\u00f3mica del SARS-CoV-2 (Proyecto PAIS). Proyecto PAIS 2021. \u3008https:\/\/www.argentina.gob.ar\/sites\/default\/files\/reporte_ndeg2-proyecto_pais-patagonia-13-07-2020_0.pdf\u3009 (accessed December 1, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib14","first-page":"188","article-title":"Secuenciaci\u00f3n del SARS-CoV-2: la iniciativa tecnol\u00f3gica para fortalecer los sistemas de alerta temprana ante emergencias de salud p\u00fablica en Latinoam\u00e9rica y el Caribe","volume":"40","author":"\u00c1lvarez-D\u00edaz","year":"2020","journal-title":"Biom. \u00e9dica"},{"key":"10.1016\/j.smim.2026.102025_bib15","unstructured":"RESVIGEN (Respiratory Virus Genomic Surveillance Regional Network) - PAHO\/WHO | Pan American Health Organization n.d. \u3008https:\/\/www.paho.org\/en\/topics\/influenza-sars-cov-2-rsv-and-other-respiratory-viruses\/resvigen-respiratory-virus-genomic\u3009 (accessed October 28, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1623413","article-title":"Genomic surveillance of SARS-CoV-2 in the Andean Community (2020-2024): integrating regional sequencing efforts from Colombia, Ecuador, Peru, and Bolivia through \u201cORAS-CONHU\u201d program","volume":"13","author":"Bruno","year":"2025","journal-title":"Front Public Health"},{"key":"10.1016\/j.smim.2026.102025_bib17","unstructured":"GISAID - Governance n.d. \u3008https:\/\/gisaid.org\/about-us\/governance\/\u3009 (accessed November 17, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/science.abh2644","article-title":"Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil","volume":"372","author":"Faria","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.smim.2026.102025_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm4908","article-title":"Characterization of the SARS-CoV-2 B.1.621 (Mu) variant","volume":"14","author":"Halfmann","year":"2022","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.smim.2026.102025_bib20","article-title":"SARS-CoV-2 Lambda (C.37): An emerging variant of concern?","volume":"25","author":"Darvishi","year":"2021","journal-title":"Gene Rep."},{"key":"10.1016\/j.smim.2026.102025_bib21","article-title":"Insights into the mutation T1117I in the spike and the lineage B.1.1.389 of SARS-CoV-2 circulating in Costa Rica","volume":"27","author":"Molina-Mora","year":"2022","journal-title":"Gene Rep."},{"key":"10.1016\/j.smim.2026.102025_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3897\/pharmacia.71.e122087","article-title":"Echoes of the pandemic: Contrasting COVID-19 outbreaks in northern Peru","volume":"71","author":"Pereira-Victorio","year":"2024","journal-title":"Pharmacia"},{"key":"10.1016\/j.smim.2026.102025_bib23","first-page":"1","article-title":"Vigilancia de variantes gen\u00e9ticas del virus SARS-CoV-2 en la Frontera Sur de M\u00e9xico","volume":"3","author":"Trampe","year":"2023","journal-title":"Rev. Mesoam. De. Invest. \u00f3N."},{"key":"10.1016\/j.smim.2026.102025_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijregi.2023.11.005","article-title":"Omicron and Delta variant prevalence detection and identification during the fourth COVID-19 wave in Mexico using wastewater-based epidemiology","volume":"10","author":"Aguayo-Acosta","year":"2024","journal-title":"IJID Reg."},{"key":"10.1016\/j.smim.2026.102025_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28781","article-title":"Effect of vaccination on COVID-19 mortality during omicron wave among highly marginalized mexican population","volume":"10","author":"\u00c1lvarez-S\u00e1nchez","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.smim.2026.102025_bib26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S1473-3099(22)00288-2","article-title":"Vaccination plus previous infection: protection during the omicron wave in Brazil","volume":"22","author":"Cerqueira-Silva","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.smim.2026.102025_bib27","unstructured":"GISAID - hCoV-19 Variants Dashboard n.d. \u3008https:\/\/gisaid.org\/hcov-19-variants-dashboard\/\u3009 (accessed October 27, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib28","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3201\/eid2706.210135","article-title":"Trends in Viral Respiratory Infections During COVID-19 Pandemic, South Korea","volume":"27","author":"Yum","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.smim.2026.102025_bib29","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/irv.12998","article-title":"International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: Association with school closures","volume":"16","author":"Billard","year":"2022","journal-title":"Influenza Other Respir. Virus"},{"key":"10.1016\/j.smim.2026.102025_bib30","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1002\/jmv.26964","article-title":"Where have all the viruses gone? Disappearance of seasonal respiratory viruses during the COVID-19 pandemic","volume":"93","author":"Tang","year":"2021","journal-title":"J. Med Virol."},{"key":"10.1016\/j.smim.2026.102025_bib31","article-title":"The burden of non-SARS-CoV2 viral lower respiratory tract infections in hospitalized children in Barcelona (Spain): A long-term, clinical, epidemiologic and economic study","volume":"17","author":"Vila","year":"2022","journal-title":"Influenza Other Respir. Virus"},{"key":"10.1016\/j.smim.2026.102025_bib32","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijid.2022.12.042","article-title":"Global patterns and drivers of influenza decline during the COVID-19 pandemic","volume":"128","author":"Bonacina","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.smim.2026.102025_bib33","doi-asserted-by":"crossref","first-page":"e978","DOI":"10.1093\/cid\/ciaa1747","article-title":"Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters","volume":"72","author":"Zhang","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.smim.2026.102025_bib34","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1001\/jama.2020.6266","article-title":"Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.smim.2026.102025_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2025.108095","article-title":"Analyzing seasonal trends of respiratory syncytial virus circulation using Latin American national surveillance database during pre- and post-COVID-19 pandemic","volume":"161","author":"Perroud","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.smim.2026.102025_bib36","article-title":"Impact of COVID-19 Policies on the Post-pandemic Resurgence of Dengue Fever in Southeast Asia and Latin America","volume":"2026","author":"America","year":"2026","journal-title":"MedRxiv"},{"key":"10.1016\/j.smim.2026.102025_bib37","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4269\/ajtmh.20-0765","article-title":"COVID-19 Response in Latin America","volume":"103","author":"Garcia","year":"2020","journal-title":"Am. J. Trop. Med Hyg."},{"key":"10.1016\/j.smim.2026.102025_bib38","series-title":"Directrices de Laboratorio para la Detecci\u00f3n y el Diagn\u00f3stico de la Infecci\u00f3n con el Virus COVID-19, 30 de marzo de 2020","author":"Organizaci\u00f3n Panamericana de la Salud (OPS)","year":"2020"},{"key":"10.1016\/j.smim.2026.102025_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22921-7","article-title":"A pseudovirus-based platform to measure neutralizing antibodies in Mexico using SARS-CoV-2 as proof-of-concept","volume":"12","author":"Cruz-Cardenas","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.smim.2026.102025_bib40","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.3390\/ijms24054609","article-title":"Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus Libraries\u2122","volume":"24","author":"Guzm\u00e1n-Bringas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.smim.2026.102025_bib41","unstructured":"Argentina.gob.ar. Investigadores\/as del CONICET, Instituto Leloir y Laboratorio Lemos desarrollan un m\u00e9todo que agiliza las muestras en testeos serol\u00f3gicos 2020. \u3008https:\/\/www.argentina.gob.ar\/noticias\/investigadoresas-del-conicet-instituto-leloir-y-laboratorio-lemos-desarrollan-un-metodo-que\u3009 (accessed November 23, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/v14122794","article-title":"Improved Expression of SARS-CoV-2 Spike RBD Using the Insect Cell-Baculovirus System","volume":"14","author":"Poodts","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.smim.2026.102025_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270388","article-title":"Performance estimation of two in-house ELISA assays for COVID-19 surveillance through the combined detection of anti-SARS-CoV-2 IgA, IgM, and IgG immunoglobulin isotypes","volume":"18","author":"Ram\u00edrez-Reveco","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2026.102025_bib44","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3390\/microorganisms9040850","article-title":"SARS-CoV-2 IgG antibodies seroprevalence and sera neutralizing activity in Mexico: A national cross-sectional study during 2020","volume":"9","author":"Mu\u00f1oz-Medina","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.smim.2026.102025_bib45","unstructured":"Sistema Nacional de Vigilancia Epidemiologica n.d. \u3008https:\/\/www.sinave.gob.mx\/\u3009 (accessed October 27, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib46","doi-asserted-by":"crossref","DOI":"10.5867\/medwave.2022.05.2560","article-title":"Vigilancia epidemiol\u00f3gica en pandemia de COVID-19: Sistema EPIVIGILA","volume":"22","author":"Taramasco","year":"2022","journal-title":"Medwave"},{"key":"10.1016\/j.smim.2026.102025_bib47","article-title":"Coronavirus (COVID-19)","author":"Mathieu","year":"2020","journal-title":"Test. Our World Data"},{"key":"10.1016\/j.smim.2026.102025_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2025.100648","article-title":"Clinical characteristics, SARS-CoV-2 variants, and outcomes of adults hospitalized due to COVID-19 in Latin American countries","volume":"80","author":"L\u00f3pez-Mac\u00edas","year":"2025","journal-title":"Clinics"},{"key":"10.1016\/j.smim.2026.102025_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245772","article-title":"In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation","volume":"16","author":"Olivas-Mart\u00ednez","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2026.102025_bib50","article-title":"First and second COVID-19 waves in Brazil: A cross-sectional study of patients\u2019 characteristics related to hospitalization and in-hospital mortality","volume":"6","author":"Zeiser","year":"2022","journal-title":"Lancet Reg. Health - Am."},{"key":"10.1016\/j.smim.2026.102025_bib51","first-page":"56","article-title":"Impact on Fatality Rates and Years of Life Lost During the COVID-19 Pandemic: The Experience of the Mexican Public Health Incident Management Command","author":"Duque-Molina","year":"2025","journal-title":"Arch. Med Res"},{"key":"10.1016\/j.smim.2026.102025_bib52","unstructured":"Study Details | NCT05282017 | LatInamerican Vaccine Effectiveness Against Hospitalizations Due to Circulating COVID-19 VoC RWE Study | ClinicalTrials.gov n.d. \u3008https:\/\/clinicaltrials.gov\/study\/NCT05282017\u3009 (accessed November 5, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib53","article-title":"Risk factors for mortality in hospitalized patients with COVID-19 from three hospitals in Peru: A retrospective cohort study","volume":"10","author":"Urrunaga-Pastor","year":"2021","journal-title":"F1000Res"},{"key":"10.1016\/j.smim.2026.102025_bib54","article-title":"Age and Comorbidities as Risk Factors for Severe COVID-19 in Mexico, before, during and after Massive Vaccination","volume":"11","author":"Dom\u00ednguez-Ram\u00edrez","year":"2023","journal-title":"Vaccin. (Basel)"},{"key":"10.1016\/j.smim.2026.102025_bib55","article-title":"Factors Associated With Hospitalization or Intensive Care Admission in Children With COVID-19 in Latin America","volume":"10","author":"L\u00f3pez-Medina","year":"2022","journal-title":"Front Pedia"},{"key":"10.1016\/j.smim.2026.102025_bib56","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12519-023-00744-4","article-title":"Coinfection of SARS-CoV-2 Omicron variant and other respiratory pathogens in children","volume":"20","author":"Li","year":"2024","journal-title":"World J. Pedia"},{"key":"10.1016\/j.smim.2026.102025_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13165","article-title":"Obesity and COVID-19 in Latin America: A tragedy of two pandemics-Official document of the Latin American Federation of Obesity Societies","volume":"22","author":"Halpern","year":"2021","journal-title":"Obes. Rev."},{"key":"10.1016\/j.smim.2026.102025_bib58","unstructured":"Nine Latin American and Caribbean countries intensify efforts to curb obesity with PAHO support - PAHO\/WHO | Pan American Health Organization n.d. \u3008https:\/\/www.paho.org\/en\/news\/4-3-2025-nine-latin-american-and-caribbean-countries-intensify-efforts-curb-obesity-paho-0\u3009 (accessed November 23, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib59","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1111\/cts.13663","article-title":"Potential biomarkers for fatal outcome prognosis in a cohort of hospitalized COVID-19 patients with pre-existing comorbidities","volume":"16","author":"Madera-Sandoval","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.smim.2026.102025_bib60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/07853890.2020.1858234","article-title":"Increased expression of hypoxia-induced factor 1\u03b1 mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients","volume":"53","author":"Taniguchi-Ponciano","year":"2021","journal-title":"Ann. Med"},{"key":"10.1016\/j.smim.2026.102025_bib61","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.arcmed.2020.11.005","article-title":"A Shift Towards an Immature Myeloid Profile in Peripheral Blood of Critically Ill COVID-19 Patients","volume":"52","author":"Vadillo","year":"2021","journal-title":"Arch. Med Res"},{"key":"10.1016\/j.smim.2026.102025_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/v15071609","article-title":"Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil","volume":"15","author":"Pacheco","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.smim.2026.102025_bib63","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2026.102025_bib64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.smim.2026.102025_bib65","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.smim.2026.102025_bib66","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.immuni.2021.05.002","article-title":"Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia","volume":"54","author":"Kreutmair","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102025_bib67","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/jir.2022.0028","article-title":"Emergency Hematopoiesis in the Pathobiology of COVID-19: The Dark Side of an Early Innate Protective Mechanism","volume":"42","author":"Balandr\u00e1n","year":"2022","journal-title":"J. Interferon Cytokine Res"},{"key":"10.1016\/j.smim.2026.102025_bib68","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.arcmed.2023.03.003","article-title":"Chronic Comorbidities in Middle Aged Patients Contribute to Ineffective Emergency Hematopoiesis in Covid-19 Fatal Outcomes","volume":"54","author":"Romo-Rodr\u00edguez","year":"2023","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.smim.2026.102025_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.769059","article-title":"Dysregulated Immune Responses in COVID-19 Patients Correlating With Disease Severity and Invasive Oxygen Requirements","volume":"12","author":"Garc\u00eda-Gonz\u00e1lez","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.smim.2026.102025_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264566","article-title":"The percentage of CD39+ monocytes is higher in pregnant COVID-19+ patients than in nonpregnant COVID-19+ patients","volume":"17","author":"C\u00e9rbulo-V\u00e1zquez","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2026.102025_bib71","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41372-022-01391-9","article-title":"Evaluation of maternal-infant dyad inflammatory cytokines in pregnancies affected by maternal SARS-CoV-2 infection in early and late gestation","volume":"42","author":"Taglauer","year":"2022","journal-title":"J. Perinatol."},{"key":"10.1016\/j.smim.2026.102025_bib72","article-title":"Cytokine responses to SARS-COV2 infection in mother-infant dyads: a systematic review and meta-analysis","volume":"11","author":"Jain","year":"2023","journal-title":"Front Pedia"},{"key":"10.1016\/j.smim.2026.102025_bib73","first-page":"21","article-title":"Inflammatory Marker and their Association with COVID-19 Severity in Pregnant Women","author":"Lisnawati","year":"2026","journal-title":"Indones. J. Obstet. Gynecol."},{"key":"10.1016\/j.smim.2026.102025_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.943563","article-title":"Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort study","volume":"13","author":"Torres-Ruiz","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.smim.2026.102025_bib75","doi-asserted-by":"crossref","unstructured":"Balsinha Pedroso R., Haniel Ara\u00fajo Ventura L., Torres L., Caliman Camatta G., Caixeta F., Souza Nascimento L., et al. COVID-19 induces senescence and exhaustion of T cells in patients with mild\/moderate and severe disease during a seven-day interval. MedRxiv 2023:2023.01.16.23284612. https:\/\/doi.org\/10.1101\/2023.01.16.23284612.","DOI":"10.1101\/2023.01.16.23284612"},{"key":"10.1016\/j.smim.2026.102025_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1223730","article-title":"COVID-19 patients display changes in lymphocyte subsets with a higher frequency of dysfunctional CD8lo T cells associated with disease severity","volume":"14","author":"Onofrio","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.smim.2026.102025_bib77","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41467-022-28232-9","article-title":"Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico","volume":"13","author":"Basto-Abreu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102025_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-022-07045-7","article-title":"Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile","volume":"22","author":"Vial","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.smim.2026.102025_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2022.106551","article-title":"Seroprevalence of SARS-CoV-2 on health professionals via Bayesian estimation: a Brazilian case study before and after vaccines","volume":"233","author":"Maior","year":"2022","journal-title":"Acta Trop."},{"key":"10.1016\/j.smim.2026.102025_bib80","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/vaccines10071002","article-title":"Immunization and SARS-CoV-2 Antibody Seroprevalence in a Country with High Vaccination Coverage: Lessons from Chile","volume":"10","author":"Aguilera","year":"2022","journal-title":"Vaccin. (Basel)"},{"key":"10.1016\/j.smim.2026.102025_bib81","article-title":"SARS-CoV-2 seroprevalence, cumulative infections, and immunity to symptomatic infection \u2013 A multistage national household survey and modelling study, Dominican Republic, June\u2013October 2021","volume":"16","author":"Nilles","year":"2022","journal-title":"Lancet Reg. Health - Am."},{"key":"10.1016\/j.smim.2026.102025_bib82","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.arcmed.2022.10.007","article-title":"Bioinformatic Analysis of B- and T-cell Epitopes from SARS-CoV-2 structural proteins and their potential cross-reactivity with emerging variants and other human Coronaviruses","volume":"53","author":"Pacheco-Olvera","year":"2022","journal-title":"Arch. Med Res"},{"key":"10.1016\/j.smim.2026.102025_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1010256","article-title":"Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico","volume":"10","author":"Dom\u00ednguez-Ram\u00edrez","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.smim.2026.102025_bib84","article-title":"Association of Obesity with SARS-CoV-2 and Its Relationship with the Humoral Response Prior to Vaccination in the State of Mexico: A Cross-Sectional Study","volume":"13","author":"Montes-Herrera","year":"2023","journal-title":"Diagn. (Basel)"},{"key":"10.1016\/j.smim.2026.102025_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127104","article-title":"Hybrid, vaccine-induced and natural immunity against SARS-CoV-2 in traditional food markets in Bolivia (2020\u22122022): A cross-sectional analysis of a serological survey","volume":"54","author":"Leyns","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2026.102025_bib86","unstructured":"Solidarity clinical trial for COVID-19 treatments n.d. \u3008https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov\/solidarity-clinical-trial-for-covid-19-treatments\u3009 (accessed November 1, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib87","doi-asserted-by":"crossref","unstructured":"Repurposed Antiviral Drugs for Covid-19 \u2014 Interim WHO Solidarity Trial Results 384 N. Engl. J. Med.2021, 49751110.1056\/NEJMOA2023184.","DOI":"10.1056\/NEJMoa2023184"},{"key":"10.1016\/j.smim.2026.102025_bib88","unstructured":"Welcome \u2014 RECOVERY Trial n.d. \u3008https:\/\/www.recoverytrial.net\/\u3009 (accessed November 17, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib89","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.smim.2026.102025_bib90","first-page":"99","article-title":"Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries","volume":"104","author":"Ahmed","year":"2021","journal-title":"Am. J. Trop. Med Hyg."},{"key":"10.1016\/j.smim.2026.102025_bib91","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.arcmed.2020.10.014","article-title":"Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with SARS-Cov-2 Infection","volume":"52","author":"C\u00e1rdenas","year":"2021","journal-title":"Arch. Med Res"},{"key":"10.1016\/j.smim.2026.102025_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.arcmed.2024.102960","article-title":"Intranasal Versus Intravenous Dexamethasone to Treat Hospitalized COVID-19 Patients: A Randomized Multicenter Clinical Trial","volume":"55","author":"C\u00e1rdenas","year":"2024","journal-title":"Arch. Med Res"},{"key":"10.1016\/j.smim.2026.102025_bib93","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-022-06075-5","article-title":"Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients","volume":"23","author":"C\u00e1rdenas","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.smim.2026.102025_bib94","article-title":"Long-Term Neuropsychiatric Sequelae of COVID-19 in an Open Population: A Prospective Pilot Study","author":"Gonz\u00e1lez Rosas","year":"2025","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.smim.2026.102025_bib95","unstructured":"Roche\u2019s phase III EMPACTA study showed Actemra\/RoActemra reduced the likelihood of needing mechanical ventilation in hospitalised patients with COVID-19 associated pneumonia n.d. \u3008https:\/\/www.roche.com\/media\/releases\/med-cor-2020-09-18\u3009 (accessed November 17, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib96","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2026.102025_bib97","unstructured":"Study Details | NCT04372186 | A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia | ClinicalTrials.gov n.d. \u3008https:\/\/clinicaltrials.gov\/study\/NCT04372186\u3009 (accessed November 1, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib98","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12941-023-00623-w","article-title":"REVIEW Open Access Pan-American Guidelines for the treatment of SARS-CoV-2\/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API)","volume":"22","author":"Naime Barbosa","year":"2023","journal-title":"Ann. Clin. Microbiol Antimicrob."},{"key":"10.1016\/j.smim.2026.102025_bib99","unstructured":"Use of Nirmatrelvir-Ritonavir, Tocilizumab and Molnupiravir for the management of patients with COVID-19 - PAHO\/WHO | Pan American Health Organization n.d. \u3008https:\/\/www.paho.org\/en\/events\/use-nirmatrelvir-ritonavir-tocilizumab-and-molnupiravir-management-patients-covid-19?\u3009 (accessed November 1, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S2213-2600(22)00006-6","article-title":"Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial","volume":"10","author":"Ely","year":"2022","journal-title":"Lancet Respir. Med"},{"key":"10.1016\/j.smim.2026.102025_bib101","unstructured":"Luxardo R., Ciapponi A., Colaci C., Alfie V., Garc\u00eda Mart\u00ed S., Bardach A., et al. Baricitinib en pacientes con COVID-19. Instituto de Efectividad Cl\u00ednica y Sanitaria (IECS); 2021."},{"key":"10.1016\/j.smim.2026.102025_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103161","article-title":"Convalescent plasma to treat COVID-19: Following the Argentinian lead","volume":"60","author":"Tiberghien","year":"2021","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.smim.2026.102025_bib103","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s12192-021-01197-2","article-title":"CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients","volume":"26","author":"Hernandez-Cede\u00f1o","year":"2021","journal-title":"Cell Stress Chaperon-.-."},{"key":"10.1016\/j.smim.2026.102025_bib104","unstructured":"Post COVID-19 Condition - PAHO\/WHO | Pan American Health Organization n.d. \u3008https:\/\/www.paho.org\/en\/topics\/coronavirus-infections\/coronavirus-disease-covid-19-pandemic\/post-covid-19-condition\u3009 (accessed November 1, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib105","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Al-Aly","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.smim.2026.102025_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102492","article-title":"Long COVID-19 in Latin America: Low prevalence, high resilience or low surveillance and difficulties accessing health care?","volume":"51","author":"Alvarez-Moreno","year":"2023","journal-title":"Travel Med Infect. Dis."},{"key":"10.1016\/j.smim.2026.102025_bib107","article-title":"Exploring long COVID condition in Latin America: Its impact on patients\u2019 activities and associated healthcare use","volume":"10","author":"Angarita-Fonseca","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.smim.2026.102025_bib108","article-title":"Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data","volume":"30","author":"Bello-Chavolla","year":"2024","journal-title":"Lancet Reg. Health - Am."},{"key":"10.1016\/j.smim.2026.102025_bib109","first-page":"144","article-title":"Clinical-epidemiological characterization of patients with long COVID in Mexico","volume":"160","author":"Carpio-Orantes","year":"2024","journal-title":"Gac. Med Mex."},{"key":"10.1016\/j.smim.2026.102025_bib110","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3390\/healthcare12141443","article-title":"Long COVID among Brazilian Adults and Elders 12 Months after Hospital Discharge: A Population-Based Cohort Study","volume":"12","author":"Salci","year":"2024","journal-title":"Healthcare"},{"key":"10.1016\/j.smim.2026.102025_bib111","article-title":"Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial","volume":"18","author":"Toledo-Roman\u00ed","year":"2023","journal-title":"Lancet Reg. Health - Am."},{"key":"10.1016\/j.smim.2026.102025_bib112","article-title":"A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study)","volume":"21","author":"Hern\u00e1ndez-Bernal","year":"2023","journal-title":"Lancet Reg. Health - Am."},{"key":"10.1016\/j.smim.2026.102025_bib113","unstructured":"Argentina approves its first COVID-19 vaccine - Buenos Aires Herald n.d. \u3008https:\/\/buenosairesherald.com\/business\/tech\/argentina-approves-its-first-covid-19-vaccine\u3009 (accessed November 1, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127045","article-title":"Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II\/III, randomized clinical trial","volume":"54","author":"Perez Marc","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2026.102025_bib115","unstructured":"Study Details | NCT05354024 | Phase II\/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) Vaccine | ClinicalTrials.gov n.d. \u3008https:\/\/clinicaltrials.gov\/study\/NCT05354024?term=butanvac&continentSelected=SA&locStr=Brazil&country=BR&viewType=Card&rank=1#publications\u3009 (accessed December 1, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib116","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26499-y","article-title":"A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses","volume":"12","author":"Sun","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102025_bib117","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01908-21","article-title":"Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX\/COVID-12-HEXAPRO (Patria), in Pigs","volume":"12","author":"Lara-Puente","year":"2021","journal-title":"MBio"},{"key":"10.1016\/j.smim.2026.102025_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127602","article-title":"Mucosal COVID-19 vaccines in clinical development","volume":"63","author":"Tscherne","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2026.102025_bib119","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41541-023-00662-6","article-title":"Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico","volume":"8","author":"Ponce-de-Le\u00f3n","year":"2023","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.smim.2026.102025_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126511","article-title":"Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX\/COVID-12 \u201cPatria\u201d recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico","volume":"43","author":"L\u00f3pez-Mac\u00edas","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.smim.2026.102025_bib121","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41541-024-00870-8","article-title":"Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges","volume":"9","author":"Warner","year":"2024","journal-title":"Npj Vaccin."},{"key":"10.1016\/j.smim.2026.102025_bib122","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1126\/sciadv.adq2887","article-title":"Phase 2\/3 study evaluating safety, immunogenicity, and noninferiority of single booster dose of AVX\/COVID-12 vaccine","volume":"11","author":"L\u00f3pez-Mac\u00edas","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.smim.2026.102025_bib123","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1565934","article-title":"Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX\/COVID-12 \u2018Patria\u2019 vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version","volume":"16","author":"Carballo-Uicab","year":"2025","journal-title":"Front Immunol."},{"key":"10.1016\/j.smim.2026.102025_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1394114","article-title":"Newcastle disease virus vector-based SARS-CoV-2 vaccine candidate AVX\/COVID-12 activates T cells and is recognized by antibodies from COVID-19 patients and vaccinated individuals","volume":"15","author":"Torres-Flores","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.smim.2026.102025_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12992-022-00801-z","article-title":"COVAX, vaccine donations and the politics of global vaccine inequity","volume":"18","author":"de Bengy Puyvall\u00e9e","year":"2022","journal-title":"Glob. Health"},{"key":"10.1016\/j.smim.2026.102025_bib126","series-title":"COVID-19 Vaccination Data: Infographic for the Americas (2020\u20132023)","author":"Organization PAH","year":"2024"},{"key":"10.1016\/j.smim.2026.102025_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.35772\/ghm.2021.01010","article-title":"COVID-19 vaccines: implementation, limitations and opportunities","volume":"3","author":"Richman","year":"2021","journal-title":"Glob. Health Med"},{"key":"10.1016\/j.smim.2026.102025_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2021.100114","article-title":"The successful COVID-19 vaccine rollout in Chile: Factors and challenges","volume":"9","author":"Castillo","year":"2021","journal-title":"Vaccin. X"},{"key":"10.1016\/j.smim.2026.102025_bib129","unstructured":"Caribbean authorCorporate:UNESCO OM and RB for S in LA and the, authorPerson:Marcela V\u00e9lez C. Covid-19 y vacunaci\u00f3n en Am\u00e9rica Latina y el Caribe: desaf\u00edos, necesidades y oportunidades 2021."},{"key":"10.1016\/j.smim.2026.102025_bib130","doi-asserted-by":"crossref","DOI":"10.1590\/0102-311xen165023","article-title":"Barriers and facilitators to vaccination in Latin America: a thematic synthesis of qualitative studies","volume":"40","author":"Roberti","year":"2024","journal-title":"Cad. Saude Publica"},{"key":"10.1016\/j.smim.2026.102025_bib131","unstructured":"PAHO will begin procuring COVID-19 vaccines to expand access in Latin America and the Caribbean - PAHO\/WHO | Pan American Health Organization n.d. \u3008https:\/\/www.paho.org\/en\/news\/11-8-2021-paho-will-begin-procuring-covid-19-vaccines-expand-access-latin-america-and\u3009 (accessed November 1, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib132","doi-asserted-by":"crossref","first-page":"410","DOI":"10.18233\/apm.v46i4.3109","article-title":"COVID-19 y recomendaciones actualizadas para la vacunaci\u00f3n de la poblaci\u00f3n pedi\u00e1trica en M\u00e9xico","volume":"46","author":"Cravioto","year":"2025","journal-title":"Acta Pedi\u00e1trica De. M\u00e9xico"},{"key":"10.1016\/j.smim.2026.102025_bib133","first-page":"123","article-title":"Preparedness for an upcoming pandemic. Recommendations by the National Academy of Medicine of Mexico","volume":"160","author":"Mac\u00edas-Hern\u00e1ndez","year":"2024","journal-title":"Gac. Med Mex."},{"key":"10.1016\/j.smim.2026.102025_bib135","unstructured":"Gu\u00edas Generales de Tratamiento para COVID\u201319 de la SMNyCT | 1 n.d. \u3008https:\/\/smnyct.org\/covid-19\/guias-generales-de-tratamiento-para-covid-19-de-la-smnyct\u3009 (accessed February 17, 2026)."},{"key":"10.1016\/j.smim.2026.102025_bib136","doi-asserted-by":"crossref","unstructured":"Asociaci\u00f3n Colombiana de Infectolog\u00eda (ACIN), Instituto de Evaluaci\u00f3n Tecnol\u00f3gica en Salud (IETS). Consenso colombiano de atenci\u00f3n, diagn\u00f3stico y manejo de la infecci\u00f3n por SARS-CoV-2\/COVID-19 en establecimientos de atenci\u00f3n de la salud. Infectio 2021;25:1\u2013491.","DOI":"10.22354\/in.v24i3.851"},{"key":"10.1016\/j.smim.2026.102025_bib137","unstructured":"Sociedad Chilena de Infectolog\u00eda (SOCHINF). Recomendaciones y Consensos Sochinf 2023. \u3008https:\/\/old.sochinf.cl\/recomendaciones-y-consensos-sochinf\/\u3009 (accessed February 17, 2026)."},{"key":"10.1016\/j.smim.2026.102025_bib138","first-page":"1","article-title":"Guidelines on the Diagnosis, Treatment and Isolation of Patients with COVID-19","volume":"9","author":"Dias","year":"2020","journal-title":"J. Infect. Control"},{"key":"10.1016\/j.smim.2026.102025_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","volume":"55","author":"Colson","year":"2020","journal-title":"Int J. Antimicrob. Agents"},{"key":"10.1016\/j.smim.2026.102025_bib140","unstructured":"El Estado de la Ciencia 2024 | UNESCO n.d. \u3008https:\/\/www.unesco.org\/es\/articles\/el-estado-de-la-ciencia-2024\u3009 (accessed December 2, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/frma.2025.1594303","article-title":"Assessing biomedical research capacities in selected countries of Latin America: challenges, opportunities, and recommendations","volume":"10","author":"Huete-Perez","year":"2025","journal-title":"Front Res Metr. Anal."},{"key":"10.1016\/j.smim.2026.102025_bib142","unstructured":"COVID-19 vaccination coverage in the EU\/EEA during the 2023\u201324 season campaigns, 1 September 2023 - 31 July 2024 n.d. \u3008https:\/\/www.ecdc.europa.eu\/en\/publications-data\/covid-19-vaccination-coverage-eueea-during-2023-24-season-campaigns-1-september\u3009 (accessed February 18, 2026)."},{"key":"10.1016\/j.smim.2026.102025_bib143","unstructured":"Aux\u00edlio Emergencial: Lessons from the Brazilian experience responding to COVID-19 n.d. \u3008https:\/\/documents.worldbank.org\/en\/publication\/documents-reports\/documentdetail\/099255012142121495\u3009 (accessed November 2, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph18020555","article-title":"Brazil\u2019s actions and reactions in the fight against COVID-19 from January to March 2020","volume":"18","author":"Szylovec","year":"2021","journal-title":"Int J. Environ. Res Public Health"},{"key":"10.1016\/j.smim.2026.102025_bib145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277327","article-title":"Financial support failure and health results: The Peruvian case","volume":"18","author":"Guillen","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2026.102025_bib146","unstructured":"S\u00e1nchez-Talanquer M., Gonz\u00e1lez-Pier E., Sep\u00falveda J., Abascal-Miguel L., Fieldhouse J., del R\u00edo C., et al. Mexico\u2019s Response to COVID-19: A Case Study. San\u00a0Francisco,\u00a0CA,\u00a0USA: Institute for Global Health Sciences, University of California, San\u00a0Francisco; 2021."},{"key":"10.1016\/j.smim.2026.102025_bib147","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/covid3090102","article-title":"Learning from Latin America: Coordinating Policy Responses across National and Subnational Levels to Combat COVID-19","volume":"3","author":"Touchton","year":"2023","journal-title":"COVID"},{"key":"10.1016\/j.smim.2026.102025_bib148","unstructured":"La pol\u00edtica del Ingreso Familiar de Emergencia (IFE) - Resumen ejecutivo | International Labour Organization n.d. \u3008https:\/\/www.ilo.org\/es\/publications\/la-politica-del-ingreso-familiar-de-emergencia-ife-resumen-ejecutivo\u3009 (accessed November 17, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib149","unstructured":"Candia A. Aprendizajes y desaf\u00edos en instrumentos de protecci\u00f3n social en emergencia: Ingreso Familiar de Emergencia (IFE). Ministerio de Desarrollo Social y Familia, Gobierno de Chile; 2021."},{"key":"10.1016\/j.smim.2026.102025_bib150","unstructured":"Impactos del programa Ingreso Solidario frente a la crisis del COVID-19 en Colombia | Publicaciones n.d. \u3008https:\/\/publications.iadb.org\/es\/publications\/spanish\/viewer\/Impactos-del-programa-Ingreso-Solidario-frente-a-la-crisis-del-COVID-19-en-Colombia.pdf\u3009 (accessed November 2, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib151","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1002\/jmv.26678","article-title":"Coronapp: A web application to annotate and monitor SARS-CoV-2 mutations","volume":"93","author":"Mercatelli","year":"2020","journal-title":"J. Med Virol."},{"key":"10.1016\/j.smim.2026.102025_bib152","article-title":"Policy responses to COVID-19 in uruguay","volume":"4","author":"Bucacos","year":"2023","journal-title":"Lat. Am. J. Cent. Bank."},{"key":"10.1016\/j.smim.2026.102025_bib153","unstructured":"Population, total | Data n.d. \u3008https:\/\/data.worldbank.org\/indicator\/SP.POP.TOTL?view=map\u3009 (accessed November 17, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib154","unstructured":"GDP per Capita by Country 2025 n.d. \u3008https:\/\/worldpopulationreview.com\/country-rankings\/gdp-per-capita-by-country\u3009 (accessed November 23, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib155","unstructured":"Comunicados y Noticias Relevantes | IPN Oficial n.d. \u3008https:\/\/www.ipn.mx\/imageninstitucional\/comunicados\/ver-comunicado.html?y=2021&n=52\u3009 (accessed October 27, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib156","doi-asserted-by":"crossref","first-page":"30756","DOI":"10.1021\/acsomega.2c01374","article-title":"Potential of ATR-FTIR-Chemometrics in Covid-19: Disease Recognition","volume":"7","author":"Calvo-Gomez","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.smim.2026.102025_bib157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279681","article-title":"Starting from scratch: Step-by-step development of diagnostic tests for SARS-CoV-2 detection by RT-LAMP","volume":"18","author":"Tapia-Sidas","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2026.102025_bib158","unstructured":"Red ISPA. La Argentina frente al COVID-19: desde las respuestas inmediatas hacia una estrategia de desarrollo de capacidades 2020. \u3008https:\/\/www.ciecti.org.ar\/wp-content\/uploads\/2021\/01\/Informe-Red-ISPA.pdf\u3009 (accessed November 23, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib159","first-page":"59","article-title":"Validaci\u00f3n cl\u00ednica de la prueba RT-LAMP para el diagn\u00f3stico r\u00e1pido del SARS-CoV-2","volume":"42","author":"Hurtado","year":"2022","journal-title":"Biom. \u00e9dica"},{"key":"10.1016\/j.smim.2026.102025_bib160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.17843\/rpmesp.2021.381.7154","article-title":"Standardization and validation of an in house RT-LAMP molecular test for the diagnosis of SARS-CoV-2","volume":"38","author":"Escalante-Maldonado","year":"2021","journal-title":"Rev. Peru. Med Exp. Salud Publica"},{"key":"10.1016\/j.smim.2026.102025_bib161","unstructured":"ICC \u2013 Instituto Carlos Chagas | Fiocruz, em parceria com IBMP e Tecpar, implanta Unidade de Apoio ao Diagn\u00f3stico Covid-19 em Curitiba n.d. \u3008https:\/\/www.icc.fiocruz.br\/fiocruz-em-parceria-com-ibmp-e-tecpar-implanta-unidade-de-apoio-ao-diagnostico-covid-19-em-curitiba\/\u3009 (accessed November 23, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib162","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijid.2020.05.098","article-title":"Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples","volume":"99","author":"Porte","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.smim.2026.102025_bib163","unstructured":"Organization W.H. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020 2020."},{"key":"10.1016\/j.smim.2026.102025_bib164","article-title":"Evidence in decision-making in the context of COVID-19 in Latin America","volume":"14","author":"Stanford","year":"2022","journal-title":"Lancet Reg. Health - Am."},{"key":"10.1016\/j.smim.2026.102025_bib165","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-025-21712-9","article-title":"Effect of Covid-19 pandemic on azithromycin, chloroquine\/hydroxychloroquine and ivermectin outpatient consumption in Brazil: a joinpoint regression analysis","volume":"25","author":"Caetano","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.smim.2026.102025_bib166","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"RECOVERY Collaborative Group","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2026.102025_bib167","unstructured":"M\u00e9xico G. de. Gu\u00eda cl\u00ednica para el tratamiento de la COVID-19 en M\u00e9xico: Consenso interinstitucional. Secretar\u00eda de Salud; 2021."},{"key":"10.1016\/j.smim.2026.102025_bib168","unstructured":"WHO recommends against the use of convalescent plasma to treat COVID-19 n.d. \u3008https:\/\/www.who.int\/news\/item\/07-12-2021-who-recommends-against-the-use-of-convalescent-plasma-to-treat-covid-19\u3009 (accessed November 23, 2025)."},{"key":"10.1016\/j.smim.2026.102025_bib169","unstructured":"Organization P.A.H. Guidelines for the Prophylaxis and Management of Patients with Non-severe COVID-19 in Latin America and the Caribbean. Abridged version, third edition 2023."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:58Z","timestamp":1792787938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532326000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":168,"alternative-id":["S1044532326000126"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2026.102025","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 in Latin America: Clinical and immunological insights, vaccine development, and lessons for pandemic preparedness","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2026.102025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102025"}}